LILRB4 on multiple myeloma cells promotes bone lesion by p-SHP2/NF-κB/RELT signal pathway
Abstract Background Leukocyte Ig-like receptor B family 4 (LILRB4) as an immune checkpoint on myeloid cells is a potential target for tumor therapy. Extensive osteolytic bone lesion is the most characteristic feature of multiple myeloma. It is unclear whether ectopic LILRB4 on multiple myeloma regul...
Na minha lista:
| Principais autores: | , , , , , , , , , , , , , , , , , , , , , , , , , , |
|---|---|
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
BMC
2024-07-01
|
| coleção: | Journal of Experimental & Clinical Cancer Research |
| Assuntos: | |
| Acesso em linha: | https://doi.org/10.1186/s13046-024-03110-y |
| Tags: |
Sem tags, seja o primeiro a adicionar uma tag!
|
